Search

Your search keyword '"Yuichiro Eguchi"' showing total 300 results

Search Constraints

Start Over You searched for: Author "Yuichiro Eguchi" Remove constraint Author: "Yuichiro Eguchi"
300 results on '"Yuichiro Eguchi"'

Search Results

1. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL)

2. The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease

3. Role of physical therapists in providing care to older adults in welfare shelters during the hyper-acute phase of a disaster: lessons learned in Wajima City, Japan, after the 2024 Noto Peninsula earthquake

4. Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver Disease

5. Clinical Characteristics of Steatotic Liver Disease Categories in a Large Cohort of Japanese Health Checkup Participants

6. The 'GU-GU-RU' project to eliminate discrimination related to the health effects of the Fukushima nuclear accident

7. A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Napabucasin Combined with Sorafenib in Japanese Patients with Unresectable Hepatocellular Carcinoma

8. Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD

9. Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes

10. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines

11. Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter study

12. ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation

13. Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review

14. Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients

15. Discordant pathological diagnosis of non‐alcoholic fatty liver disease: A prospective multicenter study

16. Assessment of tumor volume and density as a measure of the response of advanced hepatocellular carcinoma to sorafenib: Application of automated measurements on computed tomography scans

17. Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study

18. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study

19. FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic

20. Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees

21. Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

22. Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

23. Influence of muscle fiber type composition on early fat accumulation under high-fat diet challenge.

24. Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1.

25. LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.

26. New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia.

27. Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™

29. Clinical features of patients with chronic liver disease in Japan related to alcohol use: Nationwide examination using alcohol use disorders identification test

32. Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)

33. Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopenia

34. Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD

35. Clinical Profiles of Asians with NAFLD: A Systematic Review and Meta-Analysis

36. Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020

37. Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease

38. A genome‐wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites

40. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines

41. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040

42. Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter study

43. Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients

44. Hepatocellular carcinoma and other complications of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A structured review of published works

45. HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort

46. ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation

47. Management of Hepatitis B Surface Antigen and Hepatitis C Antibody-Positive Patients by Departments Not Specializing in Hepatology at a Suburban University Hospital in Japan: A Single-Center Observational Study

49. Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients

50. FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients

Catalog

Books, media, physical & digital resources